1. X
  2. Anju Software
Log inSign up
Anju Software
875 posts
Anju Software profile banner
user avatar

Anju Software

@AnjuSoftware
Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science.
Tempe, AZ
anjusoftware.com
Joined September 2018
119
Following
124
Followers
RepliesRepliesMediaMedia
  • user avatar
    Anju Software
    @AnjuSoftware
    Aug 19
    Responsible AI in Medical Information requires more than speed. It needs approved content, human review, traceability and lifecycle monitoring. Explore five controls for governed, reviewable workflows: hubs.la/Q04trfg80 #MedicalAffairs #ResponsibleAI
    Image
    AI in Medical Information: 5 Controls Teams Need - Anju Software
    From anjusoftware.com
  • user avatar
    Anju Software
    @AnjuSoftware
    Aug 18
    IRMS MAX 7.3.1 brings GPT-5 support, Agentic AI Case Query, Windows + SQL Server 2025 compatibility, improved AI relevance and new Zoom integration capabilities. A stronger operating environment for Medical Information.
    Image
  • user avatar
    Anju Software
    @AnjuSoftware
    Aug 18
    How many times is one Medical Information inquiry captured before it becomes a review-ready case? IRMS Assist helps preserve voice/email context and structure the case inside IRMS MAX — with less reconstruction before expert review.
    Image
  • user avatar
    Anju Software
    @AnjuSoftware
    Aug 12
    We’re proud to share that Anju Software has been named to the Everest Group Top 50™ Pharmaceutical Technology Providers 2026—recognizing our presence across clinical development and sales and marketing. Explore the research: hubs.la/Q04sG-Xl0 #LifeSciences #PharmaTech
    Image
  • user avatar
    Anju Software
    @AnjuSoftware
    Jun 24
    On #MedCommsDay, we celebrate the people behind scientific literacy and the #PrideInProfession that turns complex science into clear, credible communication. Discover PubStrat MAX: hubs.la/Q04mtGtJ0
    Image

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Advertisement
Advertisement